Back to Search
MOHAMED DARWISH, MD
MD
Otolaryngology Physician
NPI: 1902476161IndividualAccepts Medicare
Specialties, Licenses & Credentials
Otolaryngology PhysicianPrimary
Otolaryngology
Code: 207Y00000X
325230(NY)48319(TX)
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
CMS Specialties
PrimaryOTOLARYNGOLOGY
Education
OTHER
Class of 2009
Research & Publications (20)
Comparison of steady-state plasma concentrations of armodafinil and modafinil late in the day following morning administration: post hoc analysis of two randomized, double-blind, placebo-controlled, multiple-dose studies in healthy male subjects.
PMID 19663522·Clin Drug Investig·2009
4-observational
Armodafinil and modafinil have substantially different pharmacokinetic profiles despite having the same terminal half-lives: analysis of data from three randomized, single-dose, pharmacokinetic studies.
PMID 19663523·Clin Drug Investig·2009
4-observational
A pharmacokinetic comparison of single doses of once-daily cyclobenzaprine extended-release 15 mg and 30 mg: a randomized, double-blind, two-period crossover study in healthy volunteers.
PMID 19243711·Clin Ther·2009
4-observational
Effect of food on the pharmacokinetics of once-daily cyclobenzaprine extended-release 30 mg: a randomized, open-label, crossover, single-centre study.
PMID 19243207·Clin Drug Investig·2009
2-rct
Comparison of the single-dose pharmacokinetics of once-daily cyclobenzaprine extended-release 30 mg and cyclobenzaprine immediate-release 10 mg three times daily in the elderly: a randomized, open-label, crossover study.
PMID 19220066·Drugs Aging·2009
4-observational
Pharmacokinetic profile of armodafinil in healthy subjects: pooled analysis of data from three randomized studies.
PMID 19133704·Clin Drug Investig·2009
8-other
Effect of primary neopharyngeal repair on acoustic characteristics of tracheoesophageal voice after total laryngectomy.
PMID 18957154·J Laryngol Otol·2009
8-other
Bioequivalence following buccal and sublingual placement of fentanyl buccal tablet 400 microg in healthy subjects.
PMID 18081355·Clin Drug Investig·2008
2-rct
Interaction profile of armodafinil with medications metabolized by cytochrome P450 enzymes 1A2, 3A4 and 2C19 in healthy subjects.
PMID 18076219·Clin Pharmacokinet·2008
1-meta
Single-dose pharmacokinetics of once-daily cyclobenzaprine extended release 30 mg versus cyclobenzaprine immediate release 10 mg three times daily in healthy young adults : a randomized, open-label, two-period crossover, single-centre study.
PMID 18991473·Clin Drug Investig·2008
4-observational
Absolute and relative bioavailability of fentanyl buccal tablet and oral transmucosal fentanyl citrate.
PMID 17322146·J Clin Pharmacol·2007
3-trial
Effect of buccal dwell time on the pharmacokinetic profile of fentanyl buccal tablet.
PMID 17714055·Expert Opin Pharmacother·2007
4-observational
Single-dose and steady-state pharmacokinetics of fentanyl buccal tablet in healthy volunteers.
PMID 17192502·J Clin Pharmacol·2007
3-trial
Absorption of fentanyl from fentanyl buccal tablet in cancer patients with or without oral mucositis: a pilot study.
PMID 17705569·Clin Drug Investig·2007
3-trial
Cholecystokinin levels in the rat brain during the estrous cycle.
PMID 17346682·Brain Res·2007
7-preclinical
Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
PMID 16861093·Clin Ther·2006
4-observational
Comparison of equivalent doses of fentanyl buccal tablets and arteriovenous differences in fentanyl pharmacokinetics.
PMID 16884321·Clin Pharmacokinet·2006
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 2401 W BELVEDERE AVE
BALTIMORE, MD 21215 - Phone
- (410) 601-7639
Quick Facts
- NPI
- 1902476161
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 3
- Years in Practice
- 17
- Publications
- 20
Are you this provider?
Claim Your Profile